Fermenta Biotech Ltd — Important, 11-08-2026: Company Update

Fermenta Biotech has submitted its Q1FY27 earnings presentation. The company reported consolidated revenue of 126.2 Cr, EBITDA of 22.4 Cr, and Profit after Tax of 9.5 Cr, with diluted EPS at 3.34. While financials showed a YoY decline against a strong prior-year base with non-recurring income, human nutrition revenue grew 24% QoQ to 76.5 Cr, and India strengthened to 47% of revenue. Other segments like APIs and Green Chemistry also saw growth. Animal nutrition volumes were softer, reflecting a strategic choice over weak prices. Post-quarter, VITADEE Green® received FSSAI approval, enhancing the plant-based vitamin D3 offering.